Concepedia

Robynne Ashe

RA

Statistics

Publications

5

Citations

423

H-Index

5

Active since

2007

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Roswell Park Comprehensive Cancer Center

Robynne Ashe is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and clinical trials.

Top concepts

Publications per year

2007–2014

5

Publications

5

Molecular Characterization of Enzalutamide-treated Bone Metastatic Castration-resistant Prostate Cancer

Eleni Efstathiou, Mark Titus, Sijin Wen et al. · European Urology · 2014 · 246 citations · Full text

, , +4

Upfront, randomized, phase 2 trial of sorafenib versus sorafenib and low‐dose interferon alfa in patients with advanced renal cell carcinoma

Eric Jonasch, Paul G. Corn, Lance C. Pagliaro et al. · Cancer · 2009 · 118 citations · Full text

MDV3100 effects on androgen receptor (AR) signaling and bone marrow testosterone concentration modulation: Apreliminary report.

Eleni Efstathiou, Mark Titus, Dimitra Tsavachidou et al. · Journal of Clinical Oncology · 2011 · 29 citations

, , +6

Randomized phase II study of sorafenib with or without low-dose IFN in patients with metastatic renal cell carcinoma

Eric Jonasch, Paul G. Corn, Robynne Ashe et al. · Journal of Clinical Oncology · 2007 · 17 citations

, , +16

A randomized phase II trial of sorafenib versus sorafenib plus low-dose interferon-alfa: Clinical results and biomarker analysis

Nizar M. Tannir, Amado J. Zurita, John V. Heymach et al. · Journal of Clinical Oncology · 2008 · 13 citations

, , +18

Rows per page

1–5 of 5